Unusual thyroiditis after recombinant interleukin-2 therapy

International Journal of STD and AIDS

Volumn 13, Issue 11, 2002, Pages 790-791

  Abad, S ^a   Blanche, P ^a   Moachon, L ^b   Brunet, A ^a   Heripret Fredouille L ^a   Sicard, D ^a   Salmon Ceron D ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b NONE   (France)

Author keywords

Human immunodeficiency virus; Interleukin 2 therapy; Thyroiditis

Indexed keywords

C REACTIVE PROTEIN; COTRIMOXAZOLE; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; RECOMBINANT INTERLEUKIN 2; TECHNETIUM 99M; THYROXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THYROID FUNCTION; TREATMENT OUTCOME; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; THYROIDITIS, SUBACUTE;

EID: 0036840419     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646202320753781     Document Type: Article

References (11)

1. Vialettes B, Guillerand MA, Viens P, et al. Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies. Acta Endocrinol (Copenh) 1993;129:31-8
2. Smith KA. Interleukin-2: Inception, impact, and implications. Science 1988;240:1169-75
3. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin and lymphokin activated killer cells. N Engl J Med 1988;318:1557-63
4. Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 1991;68:2384-90
5. Tartour E, Schlumberger M, Dorval T, Baudin E, Fridman WH. Endocrine involvement in immunotherapy. Ann Endocrinol 1995;56:143-8
6. Espino Montoro A, Medina Perez M, Gonzales Martin MC, Asencio Marchante R, Lopez Chozas JM. Subacute thyroiditis associated with positive antibodies to Epstein-Barr virus. Ann Med Interna 2000;17:546-8
7. Cheryl R, Rosenfeld DO, Leonard H, Calabrese DO. Progression of autoimmune thyroiditis in an HIV-infected woman on HAART. The AIDS Reader 1999;9:393-7
8. Mier JW, Vachino G, Klempner MS, et al. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: Prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood 1991;78:1389-90
9. Rabinovici R, Feuerstein G, Abdullah F, et al. Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury. Circ Res 1996;78:329-36
10. I organification and thyroid hormone release by interleukin, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990;70:1735-43
11. Parana R, Cruz M, Lyra L, Cruz T. Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus. J Viral Hepatol 2000;7:393-5